Skip to main content

Table 3 Search strategya

From: Prognostic role of neutrophil-to-lymphocyte ratio in breast cancer: a systematic review and meta-analysis

Number Searches Results Type
1 exp Breast Neoplasms/ 241,242 Advanced
2 (breast? adj6 cancer*).mp,kw. 203,097 Advanced
3 (breast? adj6 neoplas*).mp,kw. 241,382 Advanced
4 (breast? adj6 carcin*).mp,kw. 62,218 Advanced
5 (breast? adj6 tumo?r*).mp,kw. 46,556 Advanced
6 (breast? adj6 adenocarcin*).mp,kw. 4642 Advanced
7 (breast? adj6 adeno-carcin*).mp,kw. 10 Advanced
8 (breast? adj6 sarcoma*).mp,kw. 1271 Advanced
9 (breast? adj6 dcis).mp,kw. 1258 Advanced
10 (breast? adj6 ductal).mp,kw. 16,064 Advanced
11 (breast? adj6 infiltrating).mp,kw. 1418 Advanced
12 (breast? adj6 intraductal).mp,kw. 2294 Advanced
13 (breast? adj6 lobular).mp,kw. 4044 Advanced
14 (breast? adj6 medullary).mp,kw. 383 Advanced
15 (breast? adj6 comedo*).mp,kw. 75 Advanced
16 (breast? adj6 metast*).mp,kw. 26,054 Advanced
17 (breast? adj2 malignan*).mp,kw. 4962 Advanced
18 (breast? adj6 onco*).mp,kw. 3338 Advanced
19 (mammar* adj6 cancer*).mp,kw. 5493 Advanced
20 (mammar* adj6 neoplas*).mp,kw. 21,985 Advanced
21 (mammar* adj6 carcin*).mp,kw. 11,584 Advanced
22 (mammar* adj6 tumo?r*).mp,kw. 18,026 Advanced
23 (mammar* adj6 adenocarcin*).mp,kw. 2958 Advanced
24 (mammar* adj6 adeno-carcin*).mp,kw. 3 Advanced
25 (mammar* adj6 sarcoma*).mp,kw. 384 Advanced
26 (mammar* adj6 ductal).mp,kw. 937 Advanced
27 (mammar* adj6 intraductal).mp,kw. 117 Advanced
28 (mammar* adj6 infiltrating).mp,kw. 201 Advanced
29 (mammar* adj6 lobular).mp,kw. 151 Advanced
30 (mammar* adj6 medullary).mp,kw. 19 Advanced
31 (mammar* adj6 comedo*).mp,kw. 6 Advanced
32 (mammar* adj6 metast*).mp,kw. 2554 Advanced
33 (mammar* adj6 malignan*).mp,kw. 1506 Advanced
34 (mammar* adj6 dcis).mp,kw. 61 Advanced
35 (ductal adj6 situ).mp,kw. 6301 Advanced
36 (ductal adj6 carcino*).mp,kw. 25,790 Advanced
37 (paget?? adj6 breast?).mp,kw. 367 Advanced
38 (paget?? adj6 nipple?).mp,kw. 363 Advanced
39 phyllodes.mp,kw. 1876 Advanced
40 phylloides.mp,kw. 206 Advanced
41 cystosarcoma*.mp,kw. 603 Advanced
42 DCIS.mp,kw. 3401 Advanced
43 or/1-40 318,397 Advanced
44 exp Ovarian Neoplasms/ 71,707 Advanced
45 (ovar* adj6 cancer*).mp,kw. 44,037 Advanced
46 (ovar* adj6 neoplas*).mp,kw. 71,929 Advanced
47 (ovar* adj6 tumo?r*).mp,kw. 24,113 Advanced
48 (ovar* adj6 malignan*).mp,kw. 7601 Advanced
49 (ovar* adj6 metasta*).mp,kw. 5781 Advanced
50 (ovar* adj6 carcin*).mp,kw. 18,742 Advanced
51 (ovar* adj6 adenocarcin*).mp,kw. 2966 Advanced
52 (ovar* adj6 adeno-carcin*).mp,kw. 12 Advanced
53 (ovar* adj6 choriocarcin*).mp,kw. 217 Advanced
54 (granulosa adj6 cancer*).mp,kw. 54 Advanced
55 (granulosa adj6 tumo?r*).mp,kw. 2699 Advanced
56 (granulosa adj6 neoplas*).mp,kw. 173 Advanced
57 (granulosa adj6 malignan*).mp,kw. 142 Advanced
58 (granulosa adj6 metasta*).mp,kw. 111 Advanced
59 (granulosa adj6 carcin*).mp,kw. 118 Advanced
60 (granulosa adj6 adenocarcin*).mp,kw. 45 Advanced
61 (granulosa adj6 adeno-carcin*).mp,kw. 0 Advanced
62 OGCTs.mp,kw. 28 Advanced
63 HBOC.mp,kw. 650 Advanced
64 Luteoma*.mp,kw. 203 Advanced
65 Sertoli-Leydig*.mp,kw. 1039 Advanced
66 Thecoma*.mp,kw. 1013 Advanced
67 (theca* adj6 tumo?r*).mp,kw. 493 Advanced
68 (ovar* adj6 dysgerminoma?).mp,kw. 467 Advanced
69 androblastoma*.mp,kw. 321 Advanced
70 arrhenoblastoma*.mp,kw. 349 Advanced
71 arrheno-blastoma*.mp,kw. 1 Advanced
72 Meig*.mp,kw. 2152 Advanced
73 or/44-72 93,590 Advanced
74 exp Endometrial Neoplasms/ 17,416 Advanced
75 (endometr* adj6 neoplas*).mp,kw. 17,866 Advanced
76 (endometr* adj6 cancer*).mp,kw. 15,307 Advanced
77 (endometr* adj6 tumo?r*).mp,kw. 5128 Advanced
78 (endometr* adj6 carcino*).mp,kw. 12,730 Advanced
79 (endometr* adj6 adenocarcin*).mp,kw. 5361 Advanced
80 (endometr* adj6 adeno-carcin*).mp,kw. 9 Advanced
81 (endometr* adj6 sarcoma*).mp,kw. 1230 Advanced
82 (endometr* adj6 malignan*).mp,kw. 2300 Advanced
83 (endometr* adj6 metast*).mp,kw. 1337 Advanced
84 (endometr* adj6 onco*).mp,kw. 370 Advanced
85 (endometr* adj6 choriocarcin*).mp,kw. 88 Advanced
86 or/74-85 31,774 Advanced
87 Uterine Cervical Neoplasms/ 65,130 Advanced
88 (cervi* adj6 cancer*).mp,kw. 41,277 Advanced
89 (cervi* adj6 neoplas*).mp,kw. 69,153 Advanced
90 (cervi* adj6 tumo?r*).mp,kw. 7715 Advanced
91 (cervi* adj6 malignan*).mp,kw. 3006 Advanced
92 (cervi* adj6 metast*).mp,kw. 6612 Advanced
93 (cervi* adj6 onco*).mp,kw. 1280 Advanced
94 (cervi* adj6 carcin*).mp,kw. 24,588 Advanced
95 (cervi* adj6 adenocarcin*).mp,kw. 2945 Advanced
96 (cervi* adj6 adeno-carcin*).mp,kw. 9 Advanced
97 (cervi* adj6 squamous*).mp,kw. 7833 Advanced
98 (cervi* adj6 adenosquamous*).mp,kw. 211 Advanced
99 (cervi* adj6 adeno-squamous*).mp,kw. 2 Advanced
100 (cervi* adj6 sarcoma*).mp,kw. 661 Advanced
101 (cervi* adj6 small cell*).mp,kw. 364 Advanced
102 (cervi* adj6 large cell*).mp,kw. 78 Advanced
103 (cervi* adj6 neuroendocrine*).mp,kw. 195 Advanced
104 (cervi* adj6 neuro-endocrine*).mp,kw. 2 Advanced
105 (cervi* adj6 choriocarcin*).mp,kw. 112 Advanced
106 SCCC.mp,kw. 46 Advanced
107 or/87-106 90,890 Advanced
108 73 or 86 or 107 199,155 Advanced
109 exp Lymphocytes/ 461,529 Advanced
110 lymphocyte?.mp,kw. 554,948 Advanced
111 (lymphoid adj2 cell?).mp,kw. 22,666 Advanced
112 (killer adj4 cell?).mp,kw. 51,337 Advanced
113 (nk adj2 cell?).mp,kw. 31,413 Advanced
114 (lak adj2 cell?).mp,kw. 2650 Advanced
115 b-lymphocyte?.mp,kw. 93,264 Advanced
116 t-lymphocyte?.mp,kw. 290,882 Advanced
117 b-lymphoid.mp,kw. 2219 Advanced
118 t-lymphoid.mp,kw. 1196 Advanced
119 (plasm adj2 cell?).mp,kw. 31 Advanced
120 plasmacyte?.mp,kw. 341 Advanced
121 (immune adj3 cell?).mp,kw. 58,743 Advanced
122 (immunocompetent adj2 cell?).mp,kw. 3494 Advanced
123 immnunocyte?.mp,kw. 0 Advanced
124 immnuno-cyte?.mp,kw. 0 Advanced
125 lymph cell?.mp,kw. 184 Advanced
126 null cell?.mp,kw. 3404 Advanced
127 immunological* competent cell?.mp,kw. 153 Advanced
128 immunoreactive cell?.mp,kw. 6231 Advanced
129 immuno-reactive cell?.mp,kw. 18 Advanced
130 prolymphocyte?.mp. 218 Advanced
131 pro-lymphocyte?.mp. 3 Advanced
132 or/109-131 648,538 Advanced
133 Neutrophils/ 77,202 Advanced
134 neutrophil*.mp,kw. 135,327 Advanced
135 (cell? adj2 le).mp,kw. 868 Advanced
136 (leukocyte? adj3 polymorphonuclear).mp,kw. 14,471 Advanced
137 pmn granulocyte?.mp,kw. 52 Advanced
138 pmn leukocyte?.mp,kw. 400 Advanced
139 (poly morphou* adj2 granulocyte?).mp,kw. 0 Advanced
140 (polynuclear adj3 leukocyte?).mp,kw. 71 Advanced
141 or/133-140 139,999 Advanced
142 (neutrophil? adj6 lymphocyte?).mp,kw. 8790 Advanced
143 NLR.mp,kw. 1729 Advanced
144 132 and 141 26,722 Advanced
145 or/142-144 27,810 Advanced
146 exp Cohort Studies/ 1,522,637 Advanced
147 exp Prognosis/ 1,240,142 Advanced
148 exp Morbidity/ 425,952 Advanced
149 exp Mortality/ 309,548 Advanced
150 exp survival analysis/ 214,369 Advanced
151 exp models, statistical/ 311,009 Advanced
152 prognos*.mp,kw. 603,945 Advanced
153 predict*.mp,kw. 1,026,266 Advanced
154 course*.mp,kw. 467,535 Advanced
155 diagnosed.mp,kw. 361,373 Advanced
156 cohort*.mp,kw. 388,862 Advanced
157 death?.mp,kw. 646,834 Advanced
158 or/146-157 4,572,550 Advanced
159 108 and 145 and 158 64 Advanced
160 43 and 145 and 158 122 Advanced
161 159 or 160 184 Advanced
162 limit 161 to yr = “2013-Current” 85 Advanced
  1. aOvid MEDLINE®, 1946–April week 2 2016